Biocon Biologics Recognised as Asia IP Elite for 2024 by IAM
Dec. 11, 2024, 8:50 a.m.
Biocon Biologics, a subsidiary of Biocon Limited, has been recognised as an Asia IP Elite for 2024 by IAM, a leading intellectual property publication.
This marks the eighth consecuti…
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.